Showing results (61-70 of 87) with videos related to
Sort By:
Pageof 9
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 3, 2018
Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experienceUri Kopylov, Irit Avni-Biron, Yulia Ron, et al.United European Gastroenterology Journal|August 19, 2020
Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort studyNathaniel Aviv Cohen, Nikolas Plevris, Uri Kopylov, et al.Inflammatory Bowel Diseases|February 9, 2017
Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World ExperienceUri Kopylov, Yulia Ron, Irit Avni-Biron, et al.Journal of Clinical Medicine|April 13, 2023
Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn's Disease: A Multi-Center Retrospective Cohort StudyAhmad Albshesh, Lian Bannon, Tali Sharar Fischler, et al.Journal of Inflammation Research|November 24, 2025
Association Between Maternal IBD-Related Antibodies and Early Life Gut Inflammatory Status and Microbiota Composition: Insights from Cord BloodTaegyu Kim, Paola Nicoletti, Maria Manuela Estevinho, et al.Biorxiv : the Preprint Server for Biology|August 13, 2025
Maternal IBD-related antibodies are associated with early life gut inflammatory status and microbiota composition: insights from cord bloodTaegyu Kim, Paola Nicoletti, Maria Manuela Estevinho, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2021
Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in IsraelIrit Avni-Biron, Ariella Bar-Gil Shitrit, Benjamin Koslowsky, et al.Alimentary Pharmacology & Therapeutics|September 28, 2022
Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort studyIrit Avni-Biron, Tali Mishael, Eran Zittan, et al.United European Gastroenterology Journal|March 28, 2020
Safety and effectiveness of ustekinumab for induction of remission in patients with Crohn's disease: A multicenter Israeli studyAriella Bar-Gil Shitrit, Ami Ben-Ya'acov, Matan Siterman, et al.Vaccines|November 11, 2022
SARS-CoV-2 IgG Antibody Levels in Women with IBD Vaccinated during PregnancyIrit Avni Biron, Yair Maayan, Tali Mishael, et al.Pageof 9